Aarti Drugs Dividend Details
Record Date
09-Feb-2026
Dividends Date
09-Feb-2026
Ex Date
09-Feb-2026
Dividend Type
Equity Share
Dividend Per Share
₹2.00
The Aarti Drugs has declared a Equity Share dividend of ₹2.00 per share. Investors should note the Aarti Drugs dividend 2026 record date is 09-Feb-2026, and the Aarti Drugs ex-dividend date is 09-Feb-2026 to confirm eligibility for the payout. This move underscores the Aarti Drugs ongoing efforts to enhance shareholder value through regular dividend distributions.
Aarti Drugs Dividend History
| Record Date | Dividend Per Share | Dividend Type | Ex-Date |
|---|---|---|---|
| 09-Feb-2026 | ₹2.00 | Equity Share | 09-Feb-2026 |
| 04-Feb-2025 | ₹1.00 | Equity Share | 04-Feb-2025 |
Upcoming Dividends by Indian Companies
View More| Company | Dividends Ratio | Announcement | Record Date | Dividends Date |
|---|---|---|---|---|
| Engineers India Ltd. | 0 | 17-Feb-2026 | 06-Mar-2026 | 06-Mar-2026 |
| Dhunseri Ventures Ltd. | 0.35 | 20-Feb-2026 | 27-Feb-2026 | 27-Feb-2026 |
| NBCC (India) Ltd. | 0.12 | 13-Feb-2026 | 25-Feb-2026 | 25-Feb-2026 |
Aarti Drugs Dividend FAQs
The latest dividend declared by Aarti Drugs is of 0.2 per share for the financial year as announced on 09-Feb-2026.
Registered shareholders who own Aarti Drugs’s shares on or before the record date of 09-Feb-2026 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 09-Feb-2026.
You can expect to receive Aarti Drugs’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 09-Feb-2026. The record date is when Aarti Drugs identifies eligible shareholders for the dividend payment.
The annual dividend paid by Aarti Drugs varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Aarti Drugs's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.
